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00 The Journal of Thoracic and Cardioackground: Cardiac remodeling has been shown to have deleterious effects at both
he global and local levels. The objective of this study is to investigate the role of
train in the initiation of structural and functional changes of myocardial tissue and
ts relation to alteration of calcium-handling proteins during cardiac remodeling
fter myocardial infarction.
ethods: Sixteen sonomicrometry transducers were placed in the left ventricular
ree wall of 9 sheep to measure the regional strain in the infarct, adjacent, and
emote myocardial regions. Hemodynamic, echocardiographic, and sonomicrometry
ata were collected before myocardial infarction, after infarction, and 2, 6, and 8
eeks after infarction. Regional myocardial tissues were collected for calcium-
andling proteins at the end study.
esults: At time of termination, end-systolic strains in 3 regionally distinct zones
remote, adjacent, and infarct) of myocardium were measured to be 14.65 1.13,
5.11  0.60 (P  .05), and 0.92  0.56 (P  .05), respectively. The regional
nd-systolic strain correlated strongly with the abundance of 2 major calcium-
andling proteins: sarcoplasmic reticulum Ca2 adenosine triphosphatase subtype
a (r2  0.68, P  .05) and phospholamban (r2  0.50, P  .05). A lesser degree
f correlation was observed between the systolic strain and the abundance of
odium/calcium exchanger type 1 protein (r2  0.17, P  .05).
onclusions: Regional strain differences can be defined in the different myocardial
egions during postinfarction cardiac remodeling. These differences in regional
train drive regionally distinct alterations in calcium-handling protein expression.
fter amyocardial infarction (MI), the heart undergoes alterations at the
myocyte level that lead to changes in global function, known as remodel-
ing.1 The International Forum on Cardiac Remodeling defines the ch
s, “genome expression, molecular, cellular and interstitial changes that are mani-
ested clinically as changes in size, shape, and function of the heart after cardiac
njury.”2 Although initially an adaptive and compensatory mechanism, progres
ardiac remodeling has a deleterious and negative impact.
Gradients of electromechanical function and associated protein expression occur
mong 3 histologically different zones.3-5 The 3 distinct zones include (1) 
elatively normal healthy myocardium (remote zone), (2) the nonischemic but
ypokinetic area near the MI (adjacent zone), and finally (3) the area of fibrosis and
car (infarct zone). The loss of mechanical function and its associated gene expres-
ion of calcium handling in the infarct zone is due to ischemic necrosis; however,
he differences between the nonischemic adjacent and remote zones are less easily
nderstood. We have been interested in the regional differences in post-MI strain
hat might explain alterations in regional function through mechanotransduction.
vascular Surgery ● October 2006
M
S
T
l
t
a
s
m
a
C
I
2
w
t
M
m
N
a
t
o
a
P
d
a
t
i
L
m
w
r
m
a
t
s
r
t
s
m
m
p
p
f
I
S
c
m
a
s
t
n
t
w
w
m
i
e
d
r
i
c
D
T
h
a
t
5
A
m
C
a
t
m
s
D
T
b
v
p
e
s
a
c
i
c
t
w
5
d
r
o t
s
i
f
c
n
e
d
Kilic et al Cardiopulmonary Support and Physiology
CS
Pethods
urgical Protocol
welve Dorsett hybrid sheep between 50 and 70 kg and bred for
aboratory use (Thomas Morris, Reisterstown, Md) were used in
he study. Nine animals were instrumented with subsequent cre-
tion of an anterior MI. The sheep were allowed to recover and
urvived for 8 to 12 weeks after the initial MI. Three noninstru-
ented animals were used for healthy tissue controls. All the
nimals received treatment in compliance with the “Guide for the
are and Use of Laboratory Animals” published by the National
nstitutes of Health (National Institutes of Health publication 85-
3, revised 1985). The surgical procedures and postoperative care
ere carried out according to the approved protocol by the Insti-
utional Animal Care and Use Committee of the University of
aryland at Baltimore.
Anesthesia was induced by thiopental sodium (10 mg/kg) and
aintained by 1% to 2% isoflurane (Draeger anesthesia monitor,
orth American Draeger, Telford, Pa). Surface electrocardiogram,
rterial blood pressure, pulse oximeter, and esophageal tempera-
ure were continuously monitored for each animal during the
perations described. The instrumented group underwent a left
nterolateral thoracotomy with excision of the left fifth rib.
olypropylene snares were placed around the first and second
iagonal coronary arteries of the left anterior descending artery
nd passed through pressure tubing. The snares were momentarily
ightened (30 seconds) to demarcate the border of the future
nfarct. Four specific transducers (2 mm; Sonometrics Corporation,
ondon, Ontario, Canada) were placed at the superior, inferior,
edial, and lateral aspects of the transiently ischemic myocardium
ith an additional transducer placed in the center of this ischemic
egion. An additional 11 transducers were sutured into the mid-
yocardium of the left ventricular (LV) free wall to create a final
rray of 3 short-axis aligned rows of 5 transducers with an addi-
ional transducer in the apex. The wires of the transducers were
ecured together with silk ties, tunneled subcutaneously, and their
espective skin buttons exposed to allow for future data acquisi-
ion. The coronary snares were tunneled subcutaneously for sub-
equent permanent vessel occlusion. An ultrasonic flow probe (20
m; Transonic Systems, Inc, Ithaca, NY) was placed around the
ain pulmonary artery for cardiac output monitoring. An atrial
ort silicone catheter (9F; Access Technologies, Stokie, Ill) was
laced into the left atrium and placed in a subcutaneous pocket for
uture myocardial perfusion measurements.
nfarction
even to 10 days later, the sheep were reanesthetized and a
Abbreviations and Acronyms
LV  left ventricular
MI myocardial infarction
NCX-1  sodium/calcium exchanger type 1
PLB  phospholamban
SERCA2a sarcoplasmic reticulum Ca2 adenosine
triphosphatase subtype 2aatheter-tip mounted pressure transducer (SPC 350; Millar Instru- f
The Journal of Thoracicents, Inc, Houston, Tex) was placed by fluoroscopy into the LV
pex via the femoral artery. A midline laparotomy was made for
ubdiaphragmatic echocardiographic imaging. After all preinfarc-
ion baseline data (sonomicrometry, echocardiogram, hemody-
amics) were recorded, the subcutaneous snares were permanently
ightened to cause an anterior MI and the animal was supported
ith epinephrine infusion. The epinephrine infusion (240 g/h)
as started at the time of initial snare occlusion and lasted for 15
inutes, at which point the ionotrope was serially weaned in
ncrements of 60 g/h every 5 minutes until the animal was off
pinephrine support. The induction of MI was seen as electrocar-
iographic changes initially and later confirmed by echocardiog-
aphy. After an additional 15 minutes off epinephrine support, all
mmediate post-MI data were collected. The midline incision was
losed and the animal was allowed to recover.
ata Collection
ransdiaphragmatic echocardiograms with sonomicrometry and
emodynamic data were collected at the time of infarction (before
nd after MI), 2 weeks and 6 weeks after MI, and at the time of
erminal study. Echocardiograms were collected with a Sonos
500 machine with a sterile covered transducer (Philips Medical,
ndover, Mass). Sonomicrometry data were collected with a com-
ercially available digital sonomicrometry system (Sonometrics
orporation). The pulmonary artery flow rate was measured with
transonic flowmeter (T401; Transonic Systems). Distance be-
ween all pairs of 16 transducers (120 unique distances) was
easured at a sampling rate of 200 samples/sec, in real time, and
ynchronized with LV pressure and pulmonary artery flow.
ata Analysis
he LV short-axis views at the tips of the papillary muscles, at the
ase of the papillary muscles, and at the apex along with long-axis
iews were studied. LV volumes and infarct size expressed as
ercentage of endocardial circumference were measured and the
jection fraction was calculated by the Bullet formula.6
By use of the signal post-processing software and multidimen-
ional scaling algorithm available from Sonometrics (Sonoview
nd Sonoxyz), the distances between the implanted 16 sonomi-
rometry transducers were first filtered to remove noises, and the
nstantaneous location of each transducer in a single 3-dimensional
oordinate system was determined. The coordinate data were used
o determine 3-dimensional motion and deformation of the LV free
all. The arrangement of the transducers consisted of 3 groups of
placed circumferentially along the LV free wall, with 1 trans-
ucer being placed into the LV apex.
The strain measure during an individual cardiac cycle is often
eferred to as the systolic strain whereas the strain measure used
ver time is referred to as the remodeling strain.7,8 For the presen
tudy, an area strain measure was used and calculated by compar-
ng the area change of the paired triangles between the reference
rame and the deformed frames. Strain measurements were then
alculated from the collected sonomicrometry transducer coordi-
ate data to compile (1) an end-systolic regional strain and (2) an
nd-diastolic (remodeling) strain over the progression of myocar-
ial remodeling.
The end-systolic regional strain was calculated with the LV
ree wall deformation during an individual cardiac cycle to
and Cardiovascular Surgery ● Volume 132, Number 4 901
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CSPssess regional myocardial contractile function. The crystal
ositions at end-diastole were used as the reference configura-
ion (frame), and subsequently the crystal positions were used
s the deformed configuration. The strains between end-diastole
nd end-systole are commonly used to assess the LV regional
ystolic function. Therefore, the negative strain during LV
ystole indicates functional contraction of myocardium. Dys-
unctional or stretched myocardium may appear to have posi-
ive systolic strain.
The end-diastolic (remodeling) strain was calculated by use of
he LV free wall deformation from the initial pre-MI geometry
uring the study period after the MI. Using crystal positions at
nd-diastole before MI and at subsequent times after MI, we
ompared the deformed configurations to the pre-MI reference
onfiguration to assess the regional change (such as, regional area
xpansion) resulting from LV remodeling.
The criteria for exclusion were (1) if the transducer did not
aintain adequate transmission for the entire duration of study
nd/or (2) if the transducer became dislodged so as not to lie in the
econstructed 3-dimensional contour of the LV free wall.
istology
t the time of the terminal study, the excised heart from each
nimal was harvested in ice-cold solution with tissue sections
aken from the 3 zones of interest; infarct, adjacent (defined as 
cm from edge of infarct), and remote zones of the LV free wall.
he tissue was examined in paraffin-embedded sections of 5-mm
uts and stained with hematoxylin and eosin as well as Masson’s
richrome stain.
egional Myocardial Perfusion
erial 3-mL injections of NuFlow fluorescent microspheres (5
illion spheres/mL, 15.5-m diameter, color-coded) (IMT Labo-
atories, Irvine, Calif) were carried out at baseline, after MI, and at
he time of terminal study using the left atrial port catheter.
eference blood samples were taken from the right femoral artery
ith a constant-withdrawal syringe (Harvard Apparatus Co, Cam-
ridge, Mass) beginning 5 seconds before microsphere injection at
constant rate of 15 mL/min for a total of 80 seconds.
After the terminal study, myocardial tissue samples from the
xcised heart were taken with correlation to the ischemic myocar-
ial borders at initial instrumentation. The tissues were separated
nto the infarct region, the adjacent region (defined as2 cm from
ABLE 1. Summary of echocardiographic data
tudy time points LVESV (mL) LVEDV (mL)
reinfarct 33.54 5.12 75.17  8.79
ostinfarct 42.86 4.37 83.36  8.41
weeks 48.82 2.73* 85.79  3.92
weeks 62.43 3.41* 95.11  7.69
erminal 74.33 10.63* 112.65 12.63
ummary of changes observed in left ventricular end-systolic volume (LV
otion abnormality (WMA), and ratio of wall motion abnormality to circu
tandard error of the mean. *P  .05 as compared with preinfarct. †P nfarct border), and the remote region. Myocardial samples along t
02 The Journal of Thoracic and Cardiovascular Surgery ● Octoith reference blood samples were sent to IMT Laboratories for
etermination of regional myocardial perfusion as described
lsewhere.8
estern Blot Analysis
or protein expression analysis, tissue samples corresponding to
ifferent regions were collected, rapidly frozen in liquid nitrogen,
nd stored at 80°C. Frozen tissue samples were homogenized in
adioimmunoprecipitation assay buffer (0.05 Tris-HCl, pH 7.4,
.15 mol/L NaCl, 0.25% deoxycholic acid, 1% NP-40, 1 mmol/L
thylenediaminetetraacetic acid, 1 mmol/L phenylmethylsulfonyl
uoride, 1 mmol/L sodium orthovanadate, 1 mmol/L sodium flu-
ride, 1 g/mL aprotinin, 1 L/mL leupeptin, and 1 L/mL
epstatin), separated by sodium dodecylsulfate–polyacrylamide
el electrophoresis, transferred to nitrocellulose polyvinylidene
ifluoride membrane, and probed with specific primary antibodies.
rotein loading was controlled by probing for glyceraldehyde-3-
hosphate dehydrogenase pseudogene (Santa Cruz Biotechnology,
anta Cruz, Calif). Expressions of sarcoplasmic reticulum Ca2
denosine triphosphatase subtype 2a (SERCA2a) at 110 kD (1:
000 dilution; Novocastra, Newcastle, United Kingdom), sodium/
alcium exchanger type 1 (NCX-1) cumulative at 120 kD and 70
D (1:500 dilution; Abcam, Cambridge, Mass), and phospholam-
an (PLB) cumulative at 25 kD and 5 kD (1:2000 dilution; Afinity
ioReagents, Golden, Colo) were digitized and quantified with
oftware (Silk Scientific, Orem, Utah; UN-SCAN-IT gel TM 5.1)
hat is sensitive to Western blot development by Enhanced Chemi-
uminescence Plus (ECL PLUS; Amersham, Piscataway, NJ).
tatistical Analysis
ata are given as mean standard error of the mean. Comparisons
etween baseline and measurements at subsequent times were
arried out by analysis of variance while comparisons between
rotein expressions were carried out with a Student paired t test.
egression analyses with correlation coefficients are as shown.
esults
emodynamics
uring the course of the study period, the heart rate, mean
rterial pressure, and cardiac output remained relatively
reserved without any statistically significant changes. The
V end-diastolic pressure, however, increased incremen-
EF (%)
WMA length
(cm) WMA/Circ
56.45  3.32 N/A N/A
48.23  3.29 3.57  0.23 0.25  0.01
43.17  1.30* 4.79  0.36† 0.31  0.02†
39.97  2.06* 5.59  0.48† 0.37  0.04†
37.07  3.35* 7.28  0.87† 0.44  0.04†
left ventricular end-diastolic volume (LVEDV), ejection fraction (EF), wall
nce (WMA/Circ). N/A, Not applicable. All values are given as mean 
compared with postinfarct.*
ESV),
mfereally during the study period. More specifically, the pres-
ber 2006
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Pures were 1.4  0.4, 1.4  0.3, 3.9  0.7 (P  .05), 6.9
0.7 (P  .05), and 8.1  0.8 mm Hg (P  .05) at
aseline, immediately post-MI, 2 weeks post-MI, 6 weeks
ost-MI, and at the time of terminal study. This observation
s consistent with previous literature in showing an increase
n LV end-diastolic pressure during cardiac remodeling and
eart failure.9
chocardiogram
chocardiographic data from the various study time points
re summarized in Table 1. The results from the mea
ent of the LV volume and global LV function showed
ncreases in LV end-systolic volume from 33.54 5.12 mL
o 74.33  10.63 mL (P .05) and end-diastolic volume
rom 75.17  8.79 mL to 112.65  12.63 mL (P  0.05)
ith a resultant decrease in ejection fraction from 56.45%
.32% to 37.07%  3.35% (P .05) during the progression
f LV remodeling. Based on analysis of the short-axis
chocardiogram around papillary muscle, infarct expansion
as observed with an increase in the length of wall motion
bnormality from 3.57  0.23 cm immediately post-MI to
.28  0.87 cm (P  .05) at the time of terminal study.
ikewise, the ratio of wall motion abnormality to endocar-
ial circumference increased from 0.25  0.01 to 0.44 
End Systolic Strain
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igure 1. Regional end-systolic strain over time. The infarct re-
ion shows loss of function immediately post-MI and shows
aradoxical dilatation by 2 weeks post-MI. The adjacent region
hows a statistically significant systolic dysfunction by 2 weeks
ost-MI with rapid progression after 6 weeks post-MI. The re-
ote region shows preserved systolic function and a nonstatis-
ically significant trend toward hypercontractility by the time of
erminal study. All values are given as mean  standard error of
he mean. *P < .05 as compared with remote region at that time
oint. †P < .05 as compared with adjacent region at that time
oint..04 (P .05), illustrating the more rapid expansion of t
The Journal of Thoracic-
nfarct tissue as compared with the adjacent and remote
yocardium.
train
erial regional end-systolic strain data from a representative
nimal over the duration of the study are shown in Fig
egative strain values (expressed as percent change over
iastolic reference) designate the functional shortening
contraction) and positive values indicate lengthening (di-
atation). At baseline, all 3 zones are noted to have relatively
ormal strain waveforms with end-systolic strain values
eing measured as12.42% 1.23%,13.75% 0.74%,
nd 13.37%  0.76% in the infarct, adjacent, and remote
ones, respectively. Immediately after MI, however, the
nfarct zone lost contractile function whereas the adjacent
nd remote zones remained unchanged. Over the duration of
he study, the systolic strain in the infarct zone approached
ero, illustrating akinesis. The adjacent and remote zones
lso exhibited different trends in systolic strain. The adja-
ent zone became hypokinetic, with gradual decrease of
train from 13.75% to 6.0%, whereas the remote zone
emained statistically unchanged.
The end-diastolic (remodeling) strain at 4 time points is
llustrated in Figure 2. Both the infarct and adjacent z
ad a progressive expansion immediately after MI with the
argest percentage of increase between 6 weeks post-MI and
he terminal study, regardless of the tissue region. The
emote zone had a much smaller remodeling strain than did
igure 2. Regional end-remodeling strain over time. The infarc-
ion region consistently shows the greatest remodeling strain
hile the adjacent region undergoes a similar remodeling strain,
lthough to a lesser degree than the infarct region. Of note, the
reatest increase in end-diastolic strain is observed between 6
eeks post-MI and the time of terminal study. All values are
iven as mean  standard error of the mean. *P < .05 as
ompared with remote region at that time point. †P < .05 as
ompared with adjacent region at that time point.he other 2 zones.
and Cardiovascular Surgery ● Volume 132, Number 4 903
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CSPistology
istologic sections of the 3 different myocardial regions
ith hematoxylin and eosin as well as Masson’s trichrome
tain are shown in Figure 3. The infarct region sh
brosis consistent with an 8- to 12-week-old MI. The adja-
ent region showed mild hypertrophy with fibrosis at the
nfarct edge. The remote region demonstrated preserved
ormal myocardium.
egional Myocardial Perfusion
he regional myocardial blood flow in the nonischemic
ones (adjacent and remote) remained constant throughout
he study period. The remote zone regional myocardial
erfusions at baseline, post-MI, and terminal study were
.09 0.07, 1.37 0.11, and 1.26 0.12 mL · min1 · g1
f tissue, whereas the adjacent zone myocardial perfusions
t the same time periods were 1.05 0.09, 1.12 0.13, and
.07  0.19 mL · min1 · g1 of tissue. In contrast, the
nfarct regional blood flows were 1.19  0.15, 0.07  0.02
P  .05) and 0.53  0.18 (P  .05).
alcium-handling Protein Expression
he abundance of the major calcium regulatory proteins,
ERCA2a, PLB, and NCX-1, in the infarct, adjacent, and
emote zones is shown in Figure 4. The infarct re
howed an 18-fold decrease in expression of SERCA2a
nd a 4-fold decrease in expression of PLB as compared
ith both the remote region and the tissues from unin-
trumented, healthy animals. Although the infarct region
howed the greatest alteration in protein expression from
ormal, the remote region showed preservation of protein
unction. c
04 The Journal of Thoracic and Cardiovascular Surgery ● Octorotein Expression as a Function of Strain
he plots of SERCA2a, PLB, and NCX-1 protein expres-
ion versus end-systolic strain are shown in Figure 
egative relationship is observed for expression of
ERCA2a (r2  0.68, P  .05) and PLB (r2  0.50, P 
05) with regard to end-systolic strain, illustrating that the
ore contractile the myocardium (ie, a more negative num-
er), the higher the expression of SERCA2a and PLB. In
ontrast, NCX-1 expression has a weaker, but positive,
orrelation with end-systolic strain (r2  0.17, P  .05).
iscussion
umerous studies on calcium handling have shown that
yocytes possess mechanosensitivity10; that is, they a
ble to use stretch (strain) activated channels in changing
alcium homeostasis. A strong relationship between stretch
nd calcium regulation dysfunction in decompensated car-
iac remodeling has been reported.11 This alteration o
alcium regulation with subsequent loss of excitation-
ontraction coupling has been implicated as playing a cen-
ral role in both systolic and diastolic contractile dysfunc-
ion.12 In addition to affecting an individual myocy
echanically distorting one cell has been shown to raise the
oncentration of intracellular calcium in a neighboring
ell.13 On a more regional level, numerous studies h
hown dysregulation of proteins and genes involved in
egional calcium handling.3,14-17 Recently, the clinical re-
vance of this mechanoelectric feedback has been demon-
trated in patients undergoing cardiopulmonary bypass.
uring weaning from cardiopulmonary support, an increase
n force and volume leads to a decrease in intracellular
Figure 3. Histologic sections of
myocardium from the infarct (A,
D), adjacent (B, E) and remote
(C, F) zones examined with Mas-
son’s trichrome (top) and hema-
toxylin and eosin (bottom) stain-
ing (magnification, 20). The
infarct zone shows marked fi-
brosis and collagen deposition.
The adjacent zone shows lesser
degree of fibrosis with myocyte
vacuolization visible on hema-
toxylin-eosin stain. The remote
zone has normal, well-pre-
served myocyte morphology.alcium and consequently decreased action potential dura-
ber 2006
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Pion, illustrating how stretch (strain) can affect excitation-
ontraction coupling via its effects on calcium.18
Both contractile strain16,19-22 and expression of calcium
andling proteins3,12,14-17,23-25 in LV myocardium hav
een studied extensively. In our present study, we investi-
ate the relationship of both the systolic strain (contractile
unction) and remodeling strain (myocardial structure de-
ormation) to alterations in protein expression during car-
iac remodeling. Our experimental purpose was 2-fold. Our
esults show that there are regional strain differences in the
nfarct, adjacent, and remote zones of the post-MI myocar-
ium. These regional strains correlate with expression of
alcium-handling proteins of the remodeled myocardium as
igure 4. A, Representative Western blots. SERCA2a, Sarcoplas-
ic reticulum calcium adenosine triphosphatase type 2a; PLB,
hospholamban; NCX-1, sodium/calcium exchanger type 1;
APDH, glyceraldehyde-3-phosphate dehydrogenase; N, normal,
eference animal; I, infarct zone in MI animal; A, adjacent zone in
I animal; R, remote zone in MI animal. B, Arbitrary density ratio
o GAPDH. All values are given as mean  standard error of the
ean. ¥P < .05 as compared with normal, adjacent, and remote
issue. *P < .05 as compared with normal ovine tissue. †P < .05
s compared with remote tissue.he end product of cardiac remodeling. t
The Journal of ThoracicWe have shown that regional differences in the systolic
unction of the post-MI myocardium follow a predictably
rogressive pattern. The end-diastolic (remodeling) changes
ere consistent with the in vivo changes observed in LV
nd-diastolic pressure and echocardiogram confirmed
hanges in LV end-diastolic volume, ejection fraction, and
all motion abnormality. Interestingly, the largest change in
olumes, ejection fraction, and remodeling strain occurred
t the period between 6 weeks post-MI and the time of
erminal study. This was also the time period when the
eduction in the end-systolic function was the greatest for
he adjacent zone myocardium. As a consequence, the re-
ote end-systolic strain trended toward hypercontractility.
he compensatory hypercontractility of the remote zone has
reviously been shown in an acute ischemia model and has
een directly correlated with mortality.24 Our findings in 
ong-term setting suggest that the critical period of decom-
ensation after post-MI remodeling in the ovine model is
rom 6 to 8 weeks after the initial ischemic event. A possible
echanism for this period of rapid change is stiffening of
he infarct tissue with resultant strain alterations in the
djacent myocardium leading to loss of function and
ypocontractility.
In addition to showing temporal regional strain gradients
mong the 3 aforementioned zones, we have correlated local
train data with site-specific expression of calcium-handling
roteins. Cardiac muscle and protein expression exhibit
ensitivity toward being structurally stretched (strained) and
here exists a feedback mechanism for excitation-
ontraction coupling. We believe that strain through mech-
notransduction is a continuous impetus for the molecular
hanges observed in cardiac remodeling. Changes in myo-
ardial remodeling strain can be seen immediately after MI
ot only on a global level but also on a more localized,
egional level. The stretch (strain) serves as the local force
rom which local alterations in protein expression and car-
iac function take place.
The potential clinical significance of this study relates to
he measurement of this driving force with the hopes of
reserving post-MI regional myocardial function. With ad-
ancements in technology, such as the 3-dimensional echo-
ardiogram, regional strain can now be measured in a non-
nvasive manner.
It is our hope that in focusing on regional strain, a strain
evel can be established that will predict when post-MI
yocardial remodeling with progression to heart failure is
ore likely to occur. The obvious clinical implication of
his strain measurement is to take early steps toward pre-
enting the development of heart failure. It has been shown
hat reduction of strain through ventricular endocardial res-
oration,25 passive constraint devices,26,27 and LV assis
evices28,29 can reverse remodeling with a near normali-
ion of cardiac function and protein expression. Our prelim-
and Cardiovascular Surgery ● Volume 132, Number 4 905
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CSPnary studies with a post-MI LV assist device–supported
nimal group (data not shown) have reduced regional re-
odeling strain with resultant near normalization of the
alcium-handling protein expression. Translation of these
ndings to clinical post-MI healing is largely dependent on
he cadence of micro–ventricular assist device and passiver
06 The Journal of Thoracic and Cardiovascular Surgery ● Octoonstraint device development. Regardless of the treatment
hosen for post-MI hearts progressing toward heart failure,
he role that strain plays in both healthy and diseased
yocardium needs to be more clearly defined.
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iscussion
r John V. Conte (Baltimore, Md). We all know that post-MI
emodeling is a very complex process that occurs at microscopic
nd macroscopic levels, and it is hard to differentiate what happens
t what time period.
You have very nicely demonstrated changes in regional strain
nd changes in protein expression. Is this a cause-and-effect rela-
ionship, or are these events that are true, true and unrelated? How
o we unify these 2 processes? I think the concept of mechano-
ransduction certainly is appealing, but how have we shown that it,
n fact, is occurring?
Second, you have demonstrated beautifully that regional strain
ffects the calcium-handling proteins. Are any other proteins af-
ected that you know of? If there are, that would tend to support
our hypothesis that, in fact, it is mechanotransduction that has
aused these changes. M
The Journal of ThoracicThird, what we have seen demonstrated here in this model is
he natural history of an MI. We know that that is not how MIs are
reated today. If you had added beta-blockers and angiotensin-
onverting enzyme inhibitors to this model, do you think you
ould have had the same results as you have demonstrated?
Passive restraint devices have been shown to reduce and in
ome cases prevent post-MI remodeling. In this model, post-MI
emodeling occurred unabated. If you had put on passive restraint
evices so that the post-MI dilation did not develop, do you have
ny evidence that you would still have these changes in protein
xpression?
Finally, you mentioned that there is a time period between 6
eeks and the end of the study that these changes in strain were
ost profound. If we as surgeons are going to intervene, and that
ould mean restraint devices or even ventricular assist devices to
ecrease the wall stress, at what time period should we intervene?
ave you shown us the ideal window for us to intervene, or is this
ust an effect that happened based on the length of time of your
tudy? If your study had continued for a longer period of time, do
ou think we might find out that there is another time period where
hese effects could become even more pronounced and we should
ait for those?
Dr Kilic. I can answer your first 2 questions regarding the
ause-and-effect relationship and other proteins-of-interest analy-
is by saying that we have investigated the role of stretch-activated
protein-coupled receptors and the phosphoinositide-3-kinases.
lassically, these families of proteins are associated with stretch-
nduced activation of apoptosis, hyperhypertophy, and contractil-
ty. In our experiments, we see the same trends of strain-graded
esponse in the adjacent and remote regions.
In terms of the beta-blockade and angiotensin-converting en-
yme inhibitors, we showed that in the remote region both strain
nd protein expression are preserved, whereas in the infarct region,
he protein expression becomes completely dysfunctional with
kinetic strain. I think if the medications (beta-blockers and an-
iotensin-converting enzyme inhibitors) were to make a differ-
nce, they would have mitigated the degree of strain loss and the
egree of protein loss in the adjacent region.
With regard to your question about the constraint device, we
ave some experience with strain offloading using a small ven-
ricular assist device in our model. In addition to the obvious
eduction in strain loss, we actually observe a near normalization
f protein expression in the adjacent region. In using the ventric-
lar assist device, we also reduce the size of the infarct and
reserve overall myocardial contractility. Our experience with the
mall ventricular assist device would likely be comparable to the
se of constraint devices, but to what degree I cannot elaborate.
Your last question regarding the window of opportunity for
ntervention is an interesting one. We do see an overall decom-
ensation that occurs between 6 weeks and the time of terminal
tudy (at 8 to 10 weeks). This is largely due to the fact that our
odel is intended to induce heart failure at around that time period.
o in terms of the best time to intervene, that is a question that we
ould hope to answer in our future studies. However, I think the
deal time will be before the adjacent region becomes decompen-
ated and the remote region becomes hypercontractile. This would
ean definitely before 6 weeks, but how early immediately after
I I cannot comment.
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CSPDr Bruno K. Podesser (Vienna, Austria). Did you really
xpect to have a lot of calcium-handling proteins in the scar left?
ormally you will find mainly fibroblasts there and very few
yocytes.
The second thing I wanted to point out is that I think extracel-
ular matrix remodeling proteins, like the tissue inhibitors of met-
lloproteinases or matrix metalloproteinases, might have influ-
nced your results even more. Could you comment on that?
Dr Kilic. Your question is very valid. How can we compare
car tissue to myocytes—basically infarct tissue with adjacent/
emote tissue?
We do have other data where we have shown with Bax, other
roteins involved in apoptosis (Akt/BAD), and matrix metallopro-
einases where there is actually an increase in protein expression
hat occurs in the infarct region.
In addition, I would point out that our protein expression for the
odium-calcium exchanger in the infarct tissue actually has in-
reased. So, in fact, there is a degree of protein expression in the
car tissue. How pertinent is protein expression in the infarct
egion? You can see a clear relationship between strain and protein t
08 The Journal of Thoracic and Cardiovascular Surgery ● Octoxpression even without the infarct tissue when you look at the
ifferences between just the adjacent and remote regions. There
xists a gradient of strain and protein expression loss as we near
he infarct region.
Dr Pedro Catarino (London, United Kingdom). One would
xpect some degree of hypertrophy even at this early stage as part
f the remodeling process.
First, how do you normalize your protein expression for the
ypertrophy?
Second, do you have a view on whether your protein expression
hanges reflect more myocyte hypertrophy or myocyte failure?
Dr Kilic. In terms of myocyte hypertrophy, we did take histo-
ogic sections from the adjacent and remote regions as well as the
nfarct region. What we observed was that the adjacent region does
how relatively more hypertrophy than the remote regions. That
eing said, the hypertrophy does not seem to be directly causing an
verexpression of protein. In fact, the adjacent region is where we
ee a loss of protein expression. Although we have not looked at
he ratio of myocyte size to protein expression, I do not believe
here would be an up-regulation resulting from hypertrophy.
ber 2006
